Troponin levels in COPD without cardiovascular influence: SCAPIS findings - Amsterdam 2025

Respiratory health, comorbidities and mortality

Chair(s): Andre F.S. Amaral, Leidy Prada

Session type: Oral presentation

Troponin levels in COPD without cardiovascular influence: SCAPIS findings

Jonas Eriksson Ström

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Alpha-1 antitrypsin deficiency associated with increased risk of venous thromboembolism: a nationwide cohort study in Denmark

Sine Voss David

Replay

Poster

Abstract

Slides

Association of triglyceride-glucose index and lung function impairment: data from the LEAD Study

Mohammad Azizzadeh

Replay

Poster

Abstract

Slides

Isolated small airways obstruction and incident cardiovascular disease in the UK Biobank

Sam Bartlett-pestell

Replay

Poster

Abstract

Slides

Cardiovascular disease and mortality in COPD real-world data from the PRAXIS study

Josefin Sundh

Replay

Poster

Abstract

Slides

Association of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with COPD incidence and all-cause mortality: A population-based study based on NHANES 2007-2016

Yu Liu

Replay

Poster

Abstract

Slides

Socioeconomic inequality in mortality among individuals with COPD and those with normal lung function but respiratory symptoms.

Sigrid Anna Aalberg Vikjord

Replay

Poster

Abstract

Slides

FEV1 and FEV1/VC trajectories based on annual spirometry measurements in relation to mortality in adults with airway obstruction

Helena Backman

Replay

Poster

Abstract

Slides

COPD and RA: Mortality risks and opportunity for intervention

Olivia Murrin

Replay

Abstract

Slides

Troponin levels in COPD without cardiovascular influence: SCAPIS findings

Jonas Eriksson Ström

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}